抗菌薬耐性診断の市場規模、シェア、動向分析レポート：技術別（微生物培養、免疫測定、PCR、NGS）、病原体別、エンドユーザー別、地域別、セグメント別予測、2022年～2030年

抗菌薬耐性診断市場の成長と動向

Grand View Research, Inc.の最新レポートによると、抗菌薬耐性診断の世界市場規模は2030年までに67億米ドルに達すると予測されています。同市場は2022年から2030年にかけてCAGR6.2%で拡大すると予測されています。特にヘルスケア施設における薬剤耐性菌感染症の発症リスクの増加や、AMRの脅威と戦うための政府・非政府組織の取り組みの増加が、市場成長の主な要因となっています。また、抗菌剤耐性を管理するために市場の主要企業が行っているさまざまな戦略的イニシアティブも、市場拡大に寄与しています。例えば、2021年3月、bioMerieuxとGIZは、AMRとの戦いを強化するためにナイジェリアの疾病管理センターを支援するために協力しました。

薬剤耐性菌感染症に対する迅速検査やPoCテストの採用が増加していることから、予測期間中に市場が拡大すると予想されます。さらに、ダナハー、アボットなどの主要な市場プレーヤーは、抗菌剤耐性感染症に対する迅速診断テストの強固な製品ポートフォリオを有しています。さらに、AMR産業連盟などの非政府組織の関与の増加は、抗菌剤耐性を管理するための診断ソリューションの開発を後押しする戦略を立てるために、規制当局を支援しています。

抗菌剤耐性感染の診断のための新規および自動化されたテストソリューションの開発に対する資金調達の増加は、予測期間中の市場成長を後押しすると予想されます。例えば、2022年5月、欧州投資銀行は、微生物疾患の完全自動化検査の研究開発のために、POCARED Diagnosticsに2400万米ドル以上の資金を提供しました。POCARED Diagnosticsは、数時間以内に結果を提供できる新規の微生物学的検査の開発に携わっています。

抗菌剤耐性は、今後数年間で増加すると予想されています。したがって、抗菌剤耐性の効果的な管理および進行の監視のために、正確かつ迅速な検査オプションの需要が増加すると予想されます。CDCによると、抗菌剤耐性に起因する年間の直接医療費は米国で約200億米ドルに上ります。

主な市場参加者は、市場での地位を強化するために、新規検査法の開発に継続的に取り組んでいます。さらに、買収、提携、協力などの他の戦略も、世界のさまざまな地域で製品ポートフォリオを拡大するために、主要なプレーヤーによって採用されています。例えば、2022年8月、Accelerate DiagnosticsとBDは、抗菌剤耐性の脅威と戦うためのコラボレーションを発表しました。この契約により、BDはAccelerate Diagnosticsの抗生物質関連耐性に関する迅速診断ソリューションを、その広大な顧客に提供することになります。

抗菌薬耐性診断市場レポートハイライト

2021年の技術分野では、高い普及率と技術の進歩により、PCRが最大のシェアを占めた

病原体別では、MRSA感染症の発症率の高さと製品上市の急増により、メチシリン耐性黄色ブドウ球菌が2021年に最大のシェアを占めた

エンドユーザーでは、患者の入院数が多く、細菌感染の発生率が高いことから、2021年の売上貢献度が最も高いのは病院セグメントであった

アジア太平洋地域では、市場プレイヤーの投資増加や研究活動の活発化により、予測期間中に最も速い成長を示すと予想される

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメントの範囲
  • 地域範囲
• 調査手法
• 情報調達
  • 購入したデータベース：
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査内容
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
    • アプローチ：商品フローアプローチ
• 調査の仮定
• 二次情報一覧
• 略語一覧
• 目的

第2章 エグゼクティブサマリー

• 市場の見通し
• 競合考察

第3章 抗菌薬耐性診断市場：変数、動向、および範囲

• 市場系列の見通し
  • 親市場
• 市場力学
  • 市場促進要因分析
    • 薬剤耐性菌感染症の発症リスクの増加
    • AMR感染症を診断するための新しい技術のイントロダクション
    • 有利な政府のイニシアチブ
  • 市場抑制要因分析
    • 診断に関する厳格な規則と規制の存在
• 浸透と成長の見通しのマッピング
• 抗菌薬耐性診断：市場分析ツール
  • 業界分析- ポーターズ
  • PESTLE分析
• 規制の枠組み
• 価格分析

第4章 抗菌薬耐性診断市場：セグメント分析、技術別、2018年から2030年

• 定義と範囲
• テクノロジー市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 世界の抗菌薬耐性診断市場、技術別、2018年から2030年
• 市場規模と予測、トレンド分析、2018年から2030年
  • 微生物培養
  • イムノアッセイ
  • PCR
  • NGS
  • 質量分析
  • ラピッド &ポイントオブケア
  • その他

第5章 抗菌薬耐性診断市場：セグメント分析、病原体別、2018年から2030年

• 定義と範囲
• 病原体市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 世界の抗菌薬耐性診断薬市場、病原体別、2018年から2030年
• 市場規模と予測、トレンド分析、2018年から2030年
  • 薬剤耐性肺炎連鎖球菌（DRSP）
  • 薬剤耐性カンピロバクター（DRC）
  • クロストリジウム・ディフィシル（CD）
  • メチシリン耐性黄色ブドウ球菌（MRSA）
  • 薬剤耐性淋菌（DRNG）
  • 薬剤耐性サルモネラ菌（DRNTS）
  • その他

第6章 抗菌薬耐性診断市場：セグメント分析、エンドユーザー別、2018年から2030年

• 定義と範囲
• エンドユーザーの市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 世界の抗菌薬耐性診断薬市場、エンドユーザー別、2018年から2030年
• 市場規模と予測、トレンド分析、2018年から2030年
  • 病院
  • 診断検査室
  • 製薬およびバイオテクノロジー企業
  • その他

第7章 抗菌薬耐性診断市場：セグメント分析、地域別、2018年から2030年

• 定義と範囲
• 地域市場シェア分析、2021年および2030年
• 地域市場ダッシュボード
• 地域市場のスナップショット
• SWOT分析
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東とアフリカ
• 市場規模、予測、収益、トレンド分析、2018年から2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スペイン
    • フランス
    • イタリア
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • MEA
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第8章 抗菌薬耐性診断市場：競合分析

• 主要な市場参入企業別最近の動向と影響分析
  • Ansoff matrix
  • Heat map analysis
  • Major Deals and Strategic Alliances Analysis
    • 合弁事業
    • ライセンシング契約
    • 製品の発売
    • カンファレンスとキャンペーン
• 会社の分類
  • イノベーター
  • 市場のリーダー
• ベンダー情勢
  • 主要なディストリビューターとチャネルパートナーのリスト
  • 主要顧客
• 公開会社
  • 競合ダッシュボード分析
    • 市場の差別化要因
• 非公開会社
  • 主要新興企業一覧
• 企業プロファイル
  • bioMerieux
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • F. Hoffmann-La Roche Ltd
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Abbott
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • BD
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Danaher
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Accelerate Diagnostics, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Molsid
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Vela Diagnostics
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Visby Medical, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ
  • Hologic, Inc.
    • 会社概要
    • 財務実績
    • 製品のベンチマーク
    • 戦略的イニシアチブ

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 Leading market players anticipated to witness highest growth
• Table 4 Global Antimicrobial Resistance Diagnostics Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 6 Global Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
• Table 7 Global Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 8 North America Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 9 North America Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 10 North America Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 11 North America Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 12 U.S. Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 13 U.S. Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
• Table 14 U.S. Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 15 Canada Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 16 Canada Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
• Table 17 Canada Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 18 Europe Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 19 Europe Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 20 Europe Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 21 Europe Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 22 Germany Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 23 Germany Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
• Table 24 Germany Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 25 France Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 26 France Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 27 France Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 28 U.K. Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 29 U.K. Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 30 U.K. Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 31 Spain Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 32 Spain Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
• Table 33 Spain Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 34 Spain Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 35 Italy Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
• Table 36 Italy Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 37 Italy Antimicrobial Resistance Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 38 Asia Pacific Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 39 Asia Pacific Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 42 Japan Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 43 Japan Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 44 Japan Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 45 China Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 46 China Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 47 China Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 48 India Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 49 India Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 50 India Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 51 Australia Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 52 Australia Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 53 Australia Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 54 South Korea Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 55 South Korea Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 56 South Korea Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 57 Latin America Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 58 Latin America Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 59 Latin America Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 60 Latin America Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 61 Brazil Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 62 Brazil Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 63 Brazil Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 64 Mexico Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 65 Mexico Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 66 Mexico Antimicrobial Resistance Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
• Table 67 Argentina Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 68 Argentina Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 69 Argentina Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 70 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 71 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 72 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 73 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By End-user, 2018 - 2030 (USD Million)
• Table 74 South Africa Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 75 South Africa Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 76 South Africa Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 77 Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 78 Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 79 Saudi Arabia Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
• Table 80 UAE Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 81 UAE Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
• Table 82 UAE Antimicrobial Resistance Diagnostics Market, By End-user, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Antimicrobial resistance diagnostics market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2020)
• Fig. 10 Strategy framework
• Fig. 11 Market driver relevance analysis (Current & future impact)
• Fig. 12 Market restraint relevance analysis (Current & future impact)
• Fig. 13 Penetration & growth prospect mapping
• Fig. 14 Porter's five forces analysis
• Fig. 15 PESTLE analysis
• Fig. 16 Antimicrobial resistance diagnostics market: technology movement analysis
• Fig. 17 Antimicrobial resistance diagnostics market: technology segment dashboard
• Fig. 18 Antimicrobial resistance diagnostics market technology outlook: Key takeaways
• Fig. 19 Microbiology culture market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 NGS market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Mass spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Rapid & point of care market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Antimicrobial resistance diagnostics market: pathogen analysis
• Fig. 27 Antimicrobial resistance diagnostics market: pathogen segment dashboard
• Fig. 28 Antimicrobial resistance diagnostics market pathogen outlook: Key takeaways
• Fig. 29 Drug Resistant Streptococcus Pneumoniae (DRSP) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 Drug Resistant Campylobacter (DRC)market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Clostridium Difficile (CD) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Methicillin Resistant Staphylococcus Aureus (MRSA)market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Drug Resistant Neisseria Gonorrhoeae (DRNG) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Drug Resistant Salmonella (DRNTS) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Antimicrobial resistance diagnostics market: end user movement analysis
• Fig. 37 Antimicrobial resistance diagnostics market: end user segment dashboard
• Fig. 38 Antimicrobial resistance diagnostics market, end user outlook: Key takeaways
• Fig. 39 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Regional outlook estimates and forecasts, 2021 & 2030
• Fig. 44 Regional market dashboard
• Fig. 45 Regional market place: Key takeaways
• Fig. 46 North America, SWOT
• Fig. 47 Europe, SWOT
• Fig. 48 Asia Pacific, SWOT
• Fig. 49 Latin America, SWOT
• Fig. 50 Middle East and Africa, SWOT
• Fig. 51 North America
• Fig. 52 North America antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 53 U.S.
• Fig. 54 U.S. antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 55 Canada
• Fig. 56 Canada antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 57 Europe
• Fig. 58 Europe antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 59 U.K.
• Fig. 60 U.K. antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 61 Germany
• Fig. 62 Germany antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 63 Spain
• Fig. 64 Spain antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 65 France
• Fig. 66 France antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 67 Italy
• Fig. 68 Italy antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 69 Asia Pacific
• Fig. 70 Asia Pacific antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 71 Japan
• Fig. 72 Japan antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 73 China
• Fig. 74 China antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 75 India
• Fig. 76 India antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 77 South Korea
• Fig. 78 South Korea antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 79 Australia
• Fig. 80 Australia antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 81 Latin America
• Fig. 82 Latin America antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 83 Brazil
• Fig. 84 Brazil antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 85 Mexico
• Fig. 86 Mexico antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 87 Argentina
• Fig. 88 Argentina antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 89 Middle East and Africa
• Fig. 90 MEA antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 91 South Africa
• Fig. 92 South Africa antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 93 Saudi Arabia
• Fig. 94 Saudi Arabia antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 95 UAE
• Fig. 96 UAE antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
• Fig. 97 Ansoff Matrix
• Fig. 98 Heat map analysis
• Fig. 99 Market differentiators

Antimicrobial Resistance Diagnostics Market Growth & Trends:

The global antimicrobial resistance diagnostics market size is expected to reach USD 6.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2022 to 2030. The increased risk of developing drug-resistant bacterial infections, especially in healthcare facilities, and increasing government & non-government bodies' efforts to combat the threat of AMR are the major factor contributing to market growth. In addition, various strategic initiatives undertaken by leading market players to manage antimicrobial resistance are also contributing to market expansion. For instance, in March 2021, bioMerieux and GIZ collaborated to support the Nigerian center for disease control to strengthen the fight against AMR.

The rising adoption of rapid testing and PoC tests for drug-resistant bacterial infections is anticipated to augment the market over the projected period. Moreover, leading market players such as Danaher, Abbott, and others have a robust product portfolio of rapid diagnostic tests for antimicrobial-resistant infections. Furthermore, the increasing involvement of non-government bodies such as AMR Industry Alliance is assisting regulatory bodies to make strategies to boost the development of diagnostic solutions to manage antimicrobial resistance.

Increasing funding for the development of novel and automated test solutions for the diagnosis of antimicrobial-resistant infections is anticipated to boost market growth over the forecast period. For instance, in May 2022, the European Investment Bank funded more than USD 24 million to POCARED Diagnostics for the R&D of fully automated testing of microbial diseases. POCARED Diagnostics is involved in the development of novel microbiology tests that can provide results within hours.

Antimicrobial resistance is expected to rise in the coming years. Hence, demand for accurate & fast testing options is expected to increase for the effective management and progression monitoring of antimicrobial resistance. According to the CDC, the annual direct healthcare expenditure of antimicrobial resistance is around USD 20 billion in the U.S. High cost of disease management is driving the demand for rapid tests for the diagnosis of infections at an early stage.

Key market players are continuously involved in the development of novel tests to strengthen their market position. Moreover, other strategies such as acquisitions, partnerships, and collaborations are also adopted by leading players to expand their product portfolio in different parts of the globe. For instance, in August 2022, Accelerate Diagnostics and BD announced a collaboration to combat the threat of antimicrobial resistance. As per the deal, BD will provide Accelerate Diagnostics rapid diagnostic solutions for antibiotics-associated resistance to its vast customers.

Antimicrobial Resistance Diagnostics Market Report Highlights:

• PCR held the largest share of the technology segment in 2021 owing to the high penetration and technological advancements

• Based on pathogen segment, the Methicillin resistant staphylococcus aureus accounted for the largest share in 2021 due to the high incidence rate of MRSA infections and the surge in product launches

• In end-user, the hospital segment was the highest revenue contributor in 2021 because of higher patient admissions and high incidence of bacterial infections

• In Asia Pacific, the market is expected to exhibit the fastest growth over the forecast period due to the rising investments by market players and increasing research activities in the region

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment scope
  • 1.1.2 Regional scope
  • 1.1.3 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased database:
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Competitive Insights

Chapter 3 Antimicrobial Resistance Diagnostics Market Variables, Trends, & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent market
• 3.2 Market Dynamics
  • 3.2.1 Market drivers analysis
    • 3.2.1.1 Increase in risk of developing drug - resistant bacterial infections
    • 3.2.1.2 Introduction of novel technologies to diagnose AMR infections
    • 3.2.1.3 Favorable government initiatives
  • 3.2.2 Market restraint analysis
    • 3.2.2.1 Presence of stringent rules and regulations pertaining to diagnostics
• 3.3 Penetration & Growth Prospect Mapping
• 3.4 Antimicrobial Resistance Diagnostics: Market Analysis Tools
  • 3.4.1 Industry analysis - Porter's
  • 3.4.2 PESTLE analysis
• 3.5 Regulatory Framework
• 3.6 Pricing Analysis

Chapter 4 Antimicrobial Resistance Diagnostics Market Segment Analysis, By Technology, 2018 - 2030 (USD Million)

• 4.1 Definition and Scope
• 4.2 Technology Market Share Analysis, 2021 & 2030
• 4.3 Segment Dashboard
• 4.4 Global Antimicrobial Resistance Diagnostics Market, by Technology, 2018 to 2030
• 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.5.1 Microbiology Culture
    • 4.5.1.1 Microbiology culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.2 Immunoassay
    • 4.5.2.1 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.3 PCR
    • 4.5.3.1 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.4 NGS
    • 4.5.4.1 NGS market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.5 Mass Spectrometry
    • 4.5.5.1 Mass Spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.6 Rapid & Point of Care
    • 4.5.6.1 Rapid & Point of Care market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.7 Others
    • 4.5.7.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5 Antimicrobial Resistance Diagnostics Market Segment Analysis, By Pathogen 2018 - 2030 (USD Million)

• 5.1 Definition and Scope
• 5.2 Pathogen Market Share Analysis, 2021 & 2030
• 5.3 Segment Dashboard
• 5.4 Global Antimicrobial Resistance Diagnostics Market, by Pathogen, 2018 to 2030
• 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.5.1 Drug Resistant Streptococcus Pneumoniae (DRSP)
    • 5.5.1.1 Drug resistant streptococcus pneumoniae (DRSP) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.2 Drug Resistant Campylobacter (DRC)
    • 5.5.2.1 Drug resistant campylobacter (DRC) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.3 Clostridium Difficile (CD)
    • 5.5.3.1 Clostridium difficile (CD) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.4 Methicillin Resistant Staphylococcus Aureus (MRSA)
    • 5.5.4.1 Methicillin resistant staphylococcus aureus (MRSA) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.5 Drug Resistant Neisseria Gonorrhoeae (DRNG)
    • 5.5.5.1 Drug resistant neisseria gonorrhoeae (DRNG) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.6 Drug Resistant Salmonella (DRNTS)
    • 5.5.6.1 Drug resistant salmonella (DRNTS) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.7 Others
    • 5.5.7.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6 Antimicrobial Resistance Diagnostics Market Segment Analysis, By End User, 2018 - 2030 (USD Million)

• 6.1 Definition and Scope
• 6.2 End User Market Share Analysis, 2021 & 2030
• 6.3 Segment Dashboard
• 6.4 Global Antimicrobial Resistance Diagnostics Market, by End User, 2018 to 2030
• 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 6.5.1 Hospitals
    • 6.5.1.1 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.2 Diagnostic Laboratories
    • 6.5.2.1 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.3 Pharmaceutical & Biotechnology Companies
    • 6.5.3.1 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5.4 Others
    • 6.5.4.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7 Antimicrobial Resistance Diagnostics Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

• 7.1 Definition & Scope
• 7.2 Regional Market Share Analysis, 2021 & 2030
• 7.3 Regional Market Dashboard
• 7.4 Regional Market Snapshot
• 7.5 SWOT Analysis
  • 7.5.1 North America
  • 7.5.2 Europe
  • 7.5.3 Asia Pacific
  • 7.5.4 Latin America
  • 7.5.5 Middle East and Africa
• 7.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030
  • 7.6.1 North America
    • 7.6.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.1.2 U.S.
    • 7.6.1.2.1 U.S. antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.1.3 Canada
    • 7.6.1.3.1 Canada antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.2 Europe
    • 7.6.2.1 Europe antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2.2 U.K.
    • 7.6.2.2.1 U.K. antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2.3 Germany
    • 7.6.2.3.1 Germany antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2.4 Spain
    • 7.6.2.4.1 Spain antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2.5 France
    • 7.6.2.5.1 France antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2.6 Italy
    • 7.6.2.6.1 Italy antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3 Asia Pacific
    • 7.6.3.1 Asia Pacific antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3.2 Japan
    • 7.6.3.2.1 Japan antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3.3 China
    • 7.6.3.3.1 China antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3.4 India
    • 7.6.3.4.1 India antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3.5 South Korea
    • 7.6.3.5.1 South Korea antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3.6 Australia
    • 7.6.3.6.1 Australia antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.4 Latin America
    • 7.6.4.1 Latin America antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4.2 Brazil
    • 7.6.4.2.1 Brazil antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4.3 Mexico
    • 7.6.4.3.1 Mexico antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4.4 Argentina
    • 7.6.4.4.1 Argentina antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.5 MEA
    • 7.6.5.1 MEA antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5.2 South Africa
    • 7.6.5.2.1 South Africa antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5.3 Saudi Arabia
    • 7.6.5.3.1 Saudi Arabia antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5.4 UAE
    • 7.6.5.4.1 UAE antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8 Antimicrobial Resistance Diagnostics Market - Competitive Analysis

• 8.1 Recent Developments & Impact Analysis, by Key Market Participants
  • 8.1.1 Ansoff matrix
  • 8.1.2 Heat map analysis
  • 8.1.3 Major Deals and Strategic Alliances Analysis
    • 8.1.3.1 Joint Ventures
    • 8.1.3.2 Licensing Agreements
    • 8.1.3.3 Product Launches
    • 8.1.3.4 Conferences and Campaigns
• 8.2 Company Categorization
  • 8.2.1 Innovators
  • 8.2.2 Market Leaders
• 8.3 Vendor Landscape
  • 8.3.1 List of key distributors and channel partners
  • 8.3.2 Key customers
• 8.4 Public Companies
  • 8.4.1 Competitive Dashboard Analysis
    • 8.4.1.1 Market Differentiators
• 8.5 Private Companies
  • 8.5.1 List of key emerging companies
• 8.6 Company Profiles
  • 8.6.1 bioMerieux
    • 8.6.1.1 Company overview
    • 8.6.1.2 Financial performance
    • 8.6.1.3 Product benchmarking
    • 8.6.1.4 Strategic initiatives
  • 8.6.2 F. Hoffmann - La Roche Ltd
    • 8.6.2.1 Company overview
    • 8.6.2.2 Financial performance
    • 8.6.2.3 Product benchmarking
    • 8.6.2.4 Strategic initiatives
  • 8.6.3 Abbott
    • 8.6.3.1 Company overview
    • 8.6.3.2 Financial performance
    • 8.6.3.3 Product benchmarking
    • 8.6.3.4 Strategic initiatives
  • 8.6.4 BD
    • 8.6.4.1 Company overview
    • 8.6.4.2 Financial performance
    • 8.6.4.3 Product benchmarking
    • 8.6.4.4 Strategic initiatives
  • 8.6.5 Danaher
    • 8.6.5.1 Company overview
    • 8.6.5.2 Financial performance
    • 8.6.5.3 Product benchmarking
    • 8.6.5.4 Strategic initiatives
  • 8.6.6 Accelerate Diagnostics, Inc.
    • 8.6.6.1 Company overview
    • 8.6.6.2 Financial performance
    • 8.6.6.3 Product benchmarking
    • 8.6.6.4 Strategic initiatives
  • 8.6.7 Molsid
    • 8.6.7.1 Company overview
    • 8.6.7.2 Financial performance
    • 8.6.7.3 Product benchmarking
    • 8.6.7.4 Strategic initiatives
  • 8.6.8 Vela Diagnostics
    • 8.6.8.1 Company overview
    • 8.6.8.2 Financial performance
    • 8.6.8.3 Product benchmarking
    • 8.6.8.4 Strategic initiatives
  • 8.6.9 Visby Medical, Inc.
    • 8.6.9.1 Company overview
    • 8.6.9.2 Financial performance
    • 8.6.9.3 Product benchmarking
    • 8.6.9.4 Strategic initiatives
  • 8.6.10 Hologic, Inc.
    • 8.6.10.1 Company overview
    • 8.6.10.2 Financial performance
    • 8.6.10.3 Product benchmarking
    • 8.6.10.4 Strategic initiatives